Peptides DB
Research-centric peptide and protocol reference hub

ARA 290 record · updated 8h ago

Healing & recoveryNeuro & moodGrade B · human evidenceResearch use only
All 13 studiesJump to the evidenceCompare
What is ARA 290 used for?

ARA 290

How it works: β-common receptor interaction

Primarily researched for · Healing & recovery

Development stage

where ARA 290 sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 9 registered trials. It describes the research record, not a recommendation.

Identity
NameARA 290
Full name—
Sequence—
ClassHealing
Research levelExtensively Studied
Discovered bypre-tracking · 2025
Pharmacology
Mechanismβ-common receptor interaction
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence0.70
Effect profile · 0–5
Healing & recovery: Healing 4.0, Muscle 0.0, Metabolic 0.0, Neuro 4.0, Sleep 0.0, Immune 3.0, Skin 0.0Healing & recovery — 4.0 / 5Neuro & mood — 4.0 / 5Inflammation & immune — 3.0 / 5HealingMuscleMetabolicNeuroSleepImmuneSkin4.00.00.04.00.03.00.0
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o mini over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 27, 2026. How this works →
Research stats
Total studies13
Human / animal / cellular5 / 4 / 0
Highest trial phasePreclinical
Years covered2015–2026
Latest study4d ago
Publication history
20152026
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

13 rows · newest 12 shownOpen in the library →
StudyTypeYearSummary depth
Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
FindingNot reported in abstract.
Animal2026Full text read0.70
Association of Fish Consumption with the Omega-3 Index and Vitamin D Status among Adolescent Females in the Southwest Coastal Zone of Bangladesh.
FindingMean O3I was 4.3% during dry season and 4.9% in wet season.
Human2026Full text read0.80
Caffeine Consumption Pattern and Associated Side Effects and Withdrawal Syndromes Among University Students of Bangladesh.
Finding34.0% drinking caffeine once daily, n=not reported in abstract.
Human2026Full text read0.80
Metabolic pathways and chemotherapy resistance in acute myeloid leukemia (AML): Insights into Enoyl-CoA hydratase domain-containing protein 3 (<i>ECHDC3</i>) as a potential therapeutic target.
FindingKnockdown of ECHDC3 significantly reduced the mitochondrial membrane potential, p < 0.0001.
Human2026Full text read0.80
Antenatal depressive symptoms impair offspring neurodevelopment by inducing maternal gut microbiota dysbiosis during pregnancy.
FindingNot reported in abstract.
Human2026Full text read0.80
Evaluation of a Risk-Stratified National Breast Screening Programme in the United Kingdom: An updated cost-effectiveness analysis
FindingNot reported in abstract.
—2024Full text read0.70
Physician experiences of electronic health records interoperability and its practical impact on care delivery in the English NHS: A cross-sectional survey study
FindingNot reported in abstract.
Human2024Full text read0.70
Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.
FindingNot reported in abstract.
review2025Full text read0.70
Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
FindingNot reported in abstract.
Animal2026Full text read0.70
Semantic Scholar search for ARA 290
TakeawayNot reported in abstract.
—2015Title only0.00
Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke.
FindingNot reported in abstract.
Animal2023Full text read0.70
The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury.
TakeawayARA290 and its derivative CHBP may offer neuroprotective benefits, but the study does not provide specific data to support these claims.
——Title only0.30